Anika Therapeutics stockholders elect directors and ratify auditor at 2024 annual meeting

Anika Therapeutics, Inc.

Elected Sheryl L. Conley, William R. Jellison, Stephen O. Richard as Class I directors (2027 term).
Ratified Deloitte & Touche LLP as independent auditor: 12,337,376 for, 43,654 against.
Say-on-pay proposal passed on a non-binding advisory basis: 11,020,273 for, 129,717 against.
Annual meeting turnout: 12,387,064 shares voted, representing 83.37% of entitled voting power.
No contested solicitations; all board proposals carried with substantial majority support.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.